Previous Page  37 / 107 Next Page
Information
Show Menu
Previous Page 37 / 107 Next Page
Page Background

Page 75

Notes:

conferenceseries

.com

Volume 6, Issue 4 (Suppl)

J Nurs Care, an open access journal

ISSN: 2167-1168

World Nursing 2017

July 10-12, 2017

23

rd

World Nursing and Healthcare Conference

July 10-12, 2017 Berlin, Germany

Vital monitoring system in patients with cancer – A cross border collaboration project (DK-DE)

Lindhardt C, Senior lecturer Dynesen A¹, Lect Jørgensen J¹, Senior lecturer Llambias MT¹, Lecturer Mærkedal ML¹, Lecturer Steen BH¹, Senior lecturer. Vestergaard

K¹, Docent Eriksen K¹

and

Docent Bjerregaard L¹

¹University College Zealand (UCSJ), Denmark

Background:

The prevalence of cancer is rising in the elder generation as development of cancer treatment increase. Subsequently a

larger population of elderly patients live with cancer. To relieve the pressure on specialized hospital wards, there is a need to develop

monitoring systems as well as integrating patients and relatives in the treatment in their own home as in the hospital.

Aim:

The aim of this study is to implement and validate vital sign technologies to test temperature, pulse blood samples in hospital

wards and in patient’s home. Further generate knowledge about patients and relatives experience and use of vital sig technologies.

Oncology nurses’ perception, attitudes and experience of care practices in relation to vital sign monitoring is explored.

Methods:

The project test four innovative vital sign technologies in patients admitted to partner hospitals in Denmark and in

Germany. The user perspective include qualitative data obtained by anthropologic observational studies, and qualitative interviews

with patients, relatives and healthcare professionals. The validation of the vital sign technologies is performed by quantitative analysis

and compared to usual measures of vital signs.

Results:

Results will be available in spring 2017 and for presentation at the Berlin conference. The project is a part of European

Union’s INTERREG 5a Program - Innocan (Innovative high technological cancer treatment Denmark-Germany). The design

includes elements according to Medical Technology Assessment. Collaborating partners include private companies aiming to get

new welfare-technological solutions into the market. Partners in the project are: University College Zealand (UCSJ), Design School

Kolding (DSK), Health Innovation Center Zealand (PFI), University Hospital Nastved (Lead Partner), University Hospital Odense,

Opeon Aps, Danish Cancer Society, University Clinic Schleswig-Holstein Lubeck, University Clinic Schleswig-Holstein Kiel, Cancer

register Schleswig-Holstein.

Biography

Christina Louise Lindhardt has completed her Ph.D. from the University of Southern Denmark at The Department of Health Sciences. Currently she is doing her

Postdoctoral studies from the same university as well as working at The University College of Zealand with research. She has published in reputed scientific

journals.

Lindhardt C et al., J Nurs Care 2017, 6:4(Suppl)

DOI: 10.4172/2167-1168-C1-049